Skip to content

Capricor Therapeutics CAPR Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

PTC Therapeutics logo
PTC TherapeuticsPTCT
-$1.18M-107%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
-$6.28M-239%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$32.85M+757%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$2.33M+919%
LeMaitre Vascular logo
LeMaitre VascularLMAT
-$1.04M+61.9%
Edgewise Therapeutics, Inc. logo
Edgewise Therapeutics, Inc.EWTX
-$3.05M-306%

Other financials

Income statement

See full
Revenue--100%
Operating income-$36.8M-47.2%
Net income-$33.9M-39.2%
EPS (diluted)-$0.59-11.3%

Balance sheet

See full
Cash & equivalents$105.4M+266%
Total debt$14.8M+1,083%
Total equity$278.7M+118%
Total assets$326.3M+112%

Cash flow

See full
Operating cash flow-$29.3M-355%
CapEx$5.1M+472%
Free cash flow-$34.4M-369%

Valuation

See full
Market cap$1.71B+303%

Profitability

See full
Operating margin-778.8%-1,038pp
Net margin-736.6%-981pp
FCF margin-563.9%-954pp

Returns & leverage

See full
Return on equity-56.4%-11.3pp
Debt / equity0.1×0.0×
Current ratio8.4×+1.9×

Where this comes from

Reported directly by Capricor Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Capricor Therapeutics's increase (decrease) in prepaid expense and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Capricor Therapeutics's increase (decrease) in prepaid expense and other assets?
Capricor Therapeutics (CAPR) reported increase (decrease) in prepaid expense and other assets of -$979.78K in Q1 2026.
How has Capricor Therapeutics's increase (decrease) in prepaid expense and other assets changed year-over-year?
Capricor Therapeutics's increase (decrease) in prepaid expense and other assets decreased by 1666.2% year-over-year, from -$55.47K to -$979.78K.
What is the long-term trend for Capricor Therapeutics's increase (decrease) in prepaid expense and other assets?
Over 3 years (2021 to 2025), Capricor Therapeutics's increase (decrease) in prepaid expense and other assets has grown at a 201.9% compound annual growth rate (CAGR), from $148.73K to $4.09M.
What does increase (decrease) in prepaid expense and other assets mean?
This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.